To view this email as a web page, click here

Today's Rundown

Featured Story

Pfizer, BioNTech nab fast track tag, prep for major phase 3 COVID-19 vax test this month

Pfizer and German mRNA partner BioNTech have grabbed an FDA fast track label as they look to start a late-stage, 30,000-patient COVID-19 vaccine test before the month is out.

read more

Top Stories

FDA spotlights eye safety in GSK anti-BCMA AdComm, but analysts expect approval anyway

The multiple myeloma field is teeming with BCMA-targeting agents, including bispecific antibodies and CAR-T therapies. GlaxoSmithKline’s antibody-drug conjugate could beat the others to market, but first it has to convince an FDA panel that its benefits outweigh eye-related side effects.

read more

Merck, Dewpoint unite to find HIV cure in deal worth up to $305M

In its second pharma deal, Dewpoint Therapeutics is teaming up with Merck to develop a new way to fight HIV using its molecular condensates platform. The duo kept specifics under wraps, but Dewpoint could net up to $305 million in upfront and milestone payments.

read more

Sponsored: Kupffer Cells in Complex In Vitro Cultures: An Important Tool For Drug Discovery

The inclusion of Kupffer cells in in vitro hepatic cultures provides researchers with advanced tools for disease modeling and drug discovery.

read more

Roche targets 2021 start for hemophilia A gene therapy phase 3 as optimization effort drags on

Roche has posted updated clinical data on a hemophilia A gene therapy it acquired in its $4.3 billion takeover of Spark Therapeutics. The study linked SPK-8011 to improvements in factor VIII expression and bleeding out as far as 3.3 years after administering the therapy, but, with Spark still optimizing the regimen, it will be 2021 before phase 3 dosing begins.

read more

Angelini lands EU rights to Ovid's phase 3 rare disease drug

Ovid Therapeutics has offloaded the European rights to OV101 in a genetic nervous system disorder to Italy’s Angelini Pharma. Angelini is paying $20 million upfront to secure a license to a drug that is due to come through a phase 3 trial in Angelman syndrome by the end of the year. 

read more

Telegenomics provider Genome Medical raises $14M, plus Samsung Catalyst partnership

Since expanding its DNA-focused telehealth work into guiding patients and institutions from genetic testing through subsequent specialty care, Genome Medical has raised $14 million to help boost its clinic-focused operations.

read more

Resources

Whitepaper: High-Loaded Dosage Forms: Novel Platform Expands Spray-Dried Dispersion Utility

A novel spray-dried dispersion platform has been developed to faciliate high drug load applications

Whitepaper: How to Harness the eISF to Accelerate Clinical Operations

Complimentary Download: How to connect to study sites remotely via the Electronic Investigator Site File (eISF) to streamline clinical operations. Insights from the largest eISF network in the world.

Whitepaper: Learn How to Navigate Pediatric Clinical Trials Under the New RACE Act

Collaboration across the industry will be key to meeting the demands of the RACE Act and ensuring pediatric patients receive the care and treatments they need.

On-Demand Webinar: Fuel gene therapy development and production with modern AAV workflows

On-demand video: fuel gene therapy development and production with modern AAV workflows.

With today’s rapidly evolving environment, we have created this five-part content series to highlight pressing issues and topics that are more pertinent today than ever before.

eBook: Cambrex eBook - Small molecules: 2020 vision

The industry trend of outsourcing to CDMOs continues. With more services, capabilities, facilities, and employees than ever before, our experts have contributed more articles to our biggest eBook yet.

White Paper: Patient Switching Behaviors Impact on Adherence and Engagement: A Predictive Analytics and Machine Learning Approach to Improving Hub Performance and Patient Outcomes

How predictive analytics and machine learning have the potential to transform healthcare by predicting “Patient Switching Behaviors.”

Whitepaper: You've Decided on a Multiparticulate Dosage Form. Now What?

Wurster processing is a versatile technique for developing and manufacturing multiparticulates for modified release dosage forms. Read this whitepaper to determine whether Wurster processing is the right option for your project.

Webinar: Blockchain Innovations that Connect & Protect Merck's Supply Chain

Get an inside look… Merck shares its next-generation approach to supply chain protection with new digital platforms, including Blockchain.

eBook: SUPERCHARGE INNOVATION: UNLEASH THE FULL FORCE OF LIFE SCIENCES

Built on advances in Artificial Intelligence (AI), data mining, and information integration into various systems at 100% accuracy, the new era of intelligent automation is integral to life sciences for devising new treatments faster and at a lower expense.

Whitepaper: 4 Ways to Keep Pace with Big Pharma, Even On a Start-Up Budget

Learn four ways to squeeze more value from your limited R&D resources.

eBook: Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies

Download this eBook and Learn the Advanced Analytical Approaches for Improved Development of Cell and Gene Therapies

Case Study: Establishing Parameters for Success

Learn about a real-world example of how clinical supply management expertise was applied to overcome inventory challenges for a complex, global study.

Fact Sheet: Forecasting to Optimize Clinical Trial Supply Management

Whether a study is simple or highly complex, forecasting and simulation reports serve as data driven communication tools to help minimize risks and keep the study on track. Learn more about forecasting solutions for informed decision making and supporting contingency planning for clinical study.

eBook: Expecting the Unexpected: Strategies for Efficient Clinical Supply Management and Forecasting

Learn how to drive excellence within the forecasting process and utilize forecasting throughout the clinical study to better plan clinical supply budgets and project timelines. Explore how to identify potential supply-related issues before they can negatively impact your study.

Events